Medicine Recall: Neuroquell 0.22 oz (6.6 mL)
Announced 2025-09-17 · FDA
The FDA is recalling Neuroquell and Neuroquell Plus distributed via the internet due to cGMP violations. The recall involves 72 containers from Atlantic Management Resources Ltd., with Lot # B-02, Batch # 1087920520, Product # R937, BBE # 31-05-21 (May 31, 2021); Batch # 1087920920, Product # R937, BBE # 31-05-21 (May 31, 2021). No corrective action is listed in the record.
| Brand | Atlantic Management Resources Ltd. |
|---|---|
| Product | Neuroquell & Neuroquell Plus, .22 fl. Oz (6.6mL),Mfg. For/Dist. By Claire Ellen Products, P.O. Box 901 Westboro, MA 01581 USA, NDC 66233712-01 |
| Reason | cGMP violations |
| Severity | moderate |
| Units affected | 72 |
| Distribution | Product was distributed via the internet. |
| Agency | FDA |
| Recall / campaign no. | Lot # B-02 Batch #: 1087920520 Product # R937 BBE#31-05-21( May 31, 2021) Batch # 1087920920 Product # R937 BBE# 31-05-21 (May 31, 2021) |
WHAT YOU SHOULD DO
- Stop using the recalled Neuroquell products immediately.
- If you have the affected product, check the listed lot/batch numbers and contact Claire Ellen Products at P.O. Box 901 Westboro, MA 01581 USA for disposal or return instructions.
- If you have experienced any adverse effects, contact your healthcare provider and report the issue to FDA MedWatch.
- Visit the FDA recall page or contact the distributor for further instructions on disposal or next steps.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.